Observe Medical ASA
OSE:OBSRV
Balance Sheet
Balance Sheet Decomposition
Observe Medical ASA
Observe Medical ASA
Balance Sheet
Observe Medical ASA
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
4
|
2
|
1
|
0
|
19
|
3
|
14
|
14
|
2
|
|
| Cash Equivalents |
4
|
2
|
1
|
0
|
19
|
3
|
14
|
14
|
2
|
|
| Total Receivables |
6
|
2
|
1
|
1
|
3
|
5
|
7
|
7
|
4
|
|
| Accounts Receivables |
1
|
0
|
1
|
0
|
1
|
1
|
5
|
3
|
3
|
|
| Other Receivables |
6
|
2
|
0
|
1
|
2
|
4
|
2
|
4
|
2
|
|
| Inventory |
1
|
1
|
2
|
3
|
8
|
7
|
8
|
7
|
5
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
11
|
6
|
4
|
4
|
30
|
15
|
29
|
27
|
12
|
|
| PP&E Net |
1
|
1
|
0
|
0
|
1
|
1
|
4
|
2
|
0
|
|
| Intangible Assets |
27
|
26
|
24
|
21
|
21
|
21
|
83
|
113
|
103
|
|
| Goodwill |
31
|
32
|
31
|
30
|
36
|
34
|
100
|
102
|
33
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
31
|
32
|
31
|
30
|
36
|
34
|
100
|
102
|
33
|
|
| Total Assets |
69
N/A
|
64
-7%
|
59
-8%
|
55
-6%
|
88
+59%
|
72
-18%
|
216
+201%
|
245
+13%
|
148
-39%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
4
|
6
|
9
|
18
|
18
|
|
| Accrued Liabilities |
0
|
1
|
0
|
1
|
2
|
4
|
6
|
11
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
7
|
45
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
28
|
23
|
25
|
0
|
0
|
0
|
0
|
5
|
22
|
|
| Other Current Liabilities |
2
|
2
|
2
|
1
|
4
|
56
|
13
|
27
|
12
|
|
| Total Current Liabilities |
31
|
26
|
30
|
3
|
10
|
72
|
72
|
61
|
60
|
|
| Long-Term Debt |
0
|
0
|
0
|
25
|
35
|
1
|
2
|
51
|
64
|
|
| Other Liabilities |
24
|
26
|
12
|
12
|
22
|
13
|
3
|
21
|
0
|
|
| Total Liabilities |
54
N/A
|
53
-3%
|
42
-20%
|
41
-3%
|
67
+65%
|
86
+27%
|
78
-10%
|
133
+71%
|
124
-6%
|
|
| Equity | ||||||||||
| Other Equity |
15
|
11
|
17
|
15
|
20
|
14
|
138
|
112
|
24
|
|
| Total Equity |
15
N/A
|
11
-23%
|
17
+48%
|
15
-14%
|
20
+40%
|
14
N/A
|
138
N/A
|
112
-19%
|
24
-78%
|
|
| Total Liabilities & Equity |
69
N/A
|
64
-7%
|
59
-8%
|
55
-6%
|
88
+59%
|
72
-18%
|
216
+201%
|
245
+13%
|
148
-39%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
2
|
5
|
13
|
19
|
|